SILO
Silo Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.16
−2.12%Next report
Analyst consensus
- Next report date
- Dec 2, 2026
- EPS estimate
- -$4.80
- Revenue estimate
- $18.0K
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.76
- EPS estimate
- -$0.32
- Revenue actual
- —
- Revenue estimate
- $18.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -18.8%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.32 | -$0.76 | Miss -137.50% | — |
| May 13, 2026 | -$0.32 | -$0.12 | Beat 62.50% | $18.0K |
| Mar 27, 2026 | — | -$0.07 | — | $18.0K |
| Nov 13, 2025 | — | -$0.12 | — | $18.0K |
| Aug 13, 2025 | — | -$0.19 | — | $18.0K |
| May 9, 2025 | — | -$0.23 | — | $18.0K |
| Mar 28, 2025 | — | -$0.41 | — | $18.0K |
| Nov 13, 2023 | -$0.21 | -$0.21 | In line | $18.0K |
| Aug 12, 2023 | -$0.32 | -$0.32 | Miss -0.37% | $18.0K |
| May 12, 2023 | — | -$0.29 | — | $18.0K |
| Mar 24, 2023 | — | -$0.78 | — | $18.0K |
| Nov 10, 2022 | — | -$0.51 | — | $18.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026